{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:24:07Z","timestamp":1790097847485,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.regpep.2007.09.012","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T15:35:18Z","timestamp":1190216118000},"page":"24-32","source":"Crossref","is-referenced-by-count":54,"title":["Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases"],"prefix":"10.1016","volume":"145","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Maderdrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.L.","family":"Lertora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vecihi","family":"Batuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2007.09.012_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"Miyata","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2007.09.012_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0006-291X(90)92140-U","article-title":"Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)","volume":"170","author":"Miyata","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2007.09.012_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2170\/jjphysiol.48.301","article-title":"Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems","volume":"48","author":"Arimura","year":"1998","journal-title":"Jpn J Physiol"},{"key":"10.1016\/j.regpep.2007.09.012_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.2000.tb06980.x","article-title":"PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex","volume":"921","author":"Vaudry","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2007.09.012_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(24)01360-7","article-title":"International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2007.09.012_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/1043-2760(93)90071-L","article-title":"Receptors for secretin, calcitonin, parathyroid hormone (PTH)\/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family","volume":"4","author":"Segre","year":"1993","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.regpep.2007.09.012_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1074\/jbc.M006923200","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kB-dependent gene activation at multiple levels in the human monocytic cell line THP-1","volume":"276","author":"Delgado","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2007.09.012_bib8","first-page":"101","article-title":"Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP","volume":"49","author":"Ganea","year":"2001","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.regpep.2007.09.012_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.regpep.2007.09.012_bib10","first-page":"207","article-title":"Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"56","author":"Abbott","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.regpep.2007.09.012_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/90.11.653","article-title":"The development of cast nephropathy in multiple myeloma","volume":"90","author":"Iggo","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.regpep.2007.09.012_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ndt\/gfi318","article-title":"Myeloma\u2014new approaches to combined nephrological\u2013haematological management","volume":"21","author":"Haubitz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.regpep.2007.09.012_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.5858\/2004-128-875-RPSIAA","article-title":"Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia","volume":"128","author":"Herrera","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.regpep.2007.09.012_bib14","first-page":"837","article-title":"Development of chronic renal failure in patients with multiple myeloma","volume":"117","author":"Ivanyi","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.regpep.2007.09.012_bib15","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.regpep.2007.09.012_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2005-10-4278","article-title":"A new twist in myeloma treatment","volume":"107","author":"Sanders","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.regpep.2007.09.012_bib17","first-page":"496","article-title":"Inhibition of Na\u2013K-ATPase activity and gene expression by a myeloma light chain in proximal tubule cells","volume":"47","author":"Guan","year":"1999","journal-title":"J Investig Med"},{"key":"10.1016\/j.regpep.2007.09.012_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/ajkd.2000.17620","article-title":"Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells","volume":"36","author":"Pote","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.regpep.2007.09.012_bib19","doi-asserted-by":"crossref","first-page":"F1245","DOI":"10.1152\/ajprenal.00350.2002","article-title":"Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells","volume":"284","author":"Sengul","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.regpep.2007.09.012_bib20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1046\/j.1523-1755.2002.00660.x","article-title":"Endocytosis of light chains induces cytokines through activation of NF-kappaB in human proximal tubule cells","volume":"62","author":"Sengul","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.regpep.2007.09.012_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1317.093","article-title":"Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38","volume":"1070","author":"Arimura","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2007.09.012_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2005-03-1186","article-title":"Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury","volume":"107","author":"Arimura","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.regpep.2007.09.012_bib23","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1074\/jbc.272.32.19666","article-title":"Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1\/2) activity in a Ras-independent, mitogen-activated protein Kinase\/ERK kinase 1 or 2-dependent manner in PC12 cells","volume":"272","author":"Barrie","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2007.09.012_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1385\/ENDO:9:2:171","article-title":"Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines","volume":"9","author":"Douziech","year":"1998","journal-title":"Endocrine"},{"key":"10.1016\/j.regpep.2007.09.012_bib25","series-title":"Pituitary adenylate cyclase-activating polypeptide","first-page":"361","article-title":"The biological significance of PACAP and PACAP receptors in human tumors: from cell lines to cancers","author":"Lelievre","year":"2003"},{"key":"10.1016\/j.regpep.2007.09.012_bib26","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1158\/0008-5472.CAN-05-2809","article-title":"Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.regpep.2007.09.012_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1681\/ASN.200602128","article-title":"Cast nephropathy in myeloma \u2014 does PACAP38, a new member of the vasoactive intestinal peptide family, open a therapeutic window?","volume":"17","author":"Ritz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.regpep.2007.09.012_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(68)90589-8","article-title":"Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis","volume":"2","author":"Risdon","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2007.09.012_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diabetes.45.4.522","article-title":"Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.09.012_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1359-6101(99)00035-0","article-title":"TGF-b in diabetic kidney disease: role of novel signaling pathways","volume":"11","author":"Sharma","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.regpep.2007.09.012_bib31","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor b is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.09.012_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2133\/dmpk.19.159","article-title":"Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity","volume":"19","author":"Nagai","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.regpep.2007.09.012_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1523-1755.2004.00718.x","article-title":"Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist","volume":"66","author":"Leung","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.regpep.2007.09.012_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6904-4-5","article-title":"S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo","volume":"4","author":"Pedraza-Chaverri","year":"2004","journal-title":"BMC Clin Pharm"},{"key":"10.1016\/j.regpep.2007.09.012_bib35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.31.6.1411","article-title":"Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat","volume":"31","author":"Reglodi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.regpep.2007.09.012_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.2000.tb06958.x","article-title":"Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions","volume":"921","author":"Reglodi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2007.09.012_bib37","first-page":"690","article-title":"Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood\u2013brain barrier","volume":"267","author":"Banks","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2007.09.012_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1749-6632.1999.tb07909.x","article-title":"VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines","volume":"897","author":"Delgado","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2007.09.012_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000127124","article-title":"Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal hormone secretion in normal men","volume":"64","author":"Chiodera","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.regpep.2007.09.012_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-5728(99)00105-8","article-title":"Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide","volume":"99","author":"Delgado","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2007.09.012_bib41","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.4049\/jimmunol.167.6.3182","article-title":"Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy","volume":"167","author":"Abad","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2007.09.012_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1183\/09031936.99.14244399","article-title":"Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides","volume":"14","author":"Linden","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.regpep.2007.09.012_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/gast.2003.50141","article-title":"Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease","volume":"124","author":"Abad","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.regpep.2007.09.012_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/gut.40.6.767","article-title":"Neurochemical coding in the small intestine of patients with Crohn's disease","volume":"40","author":"Belai","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.regpep.2007.09.012_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfmuller","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.regpep.2007.09.012_bib46","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2007.09.012_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.53.082901.103909","article-title":"Multiple sclerosis","volume":"53","author":"Keegan","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.regpep.2007.09.012_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/1352458504ms1096oa","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells","volume":"10","author":"Kato","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.regpep.2007.09.012_bib49","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2174\/0929867033456648","article-title":"Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus","volume":"10","author":"Holz","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.regpep.2007.09.012_bib50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI9387","article-title":"PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance","volume":"105","author":"Jamen","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2007.09.012_bib51","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0021-9258(17)42256-3","article-title":"Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells","volume":"269","author":"Yada","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2007.09.012_bib52","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1210\/jc.82.9.3093","article-title":"Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans","volume":"82","author":"Filipsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2007.09.012_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/154411130201300303","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity","volume":"13","author":"Ganea","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.regpep.2007.09.012_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(24)01449-2","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2007.09.012_bib55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/er.21.6.619","article-title":"The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)\/glucagon superfamily","volume":"21","author":"Sherwood","year":"2000","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.regpep.2007.09.012_bib56","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1172\/JCI112679","article-title":"Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus","volume":"78","author":"Frohman","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2007.09.012_bib57","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/en.136.8.3585","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2007.09.012_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.regpep.2007.09.012_bib59","series-title":"Endocrine Society (70th annual meeting), New Orleans, Louisiana","first-page":"86","article-title":"Degradation and bioactivities of human growth hormone releasing factor-(1-29)-amide (GRF-29) and its related peptides","author":"Sawano","year":"1988"},{"key":"10.1016\/j.regpep.2007.09.012_bib60","doi-asserted-by":"crossref","first-page":"22418","DOI":"10.1074\/jbc.M212355200","article-title":"The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38)","volume":"278","author":"Zhu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2007.09.012_bib61","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(96)00716-0","article-title":"Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide","volume":"736","author":"Uchida","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2007.09.012_bib62","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.09.012_bib63","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","article-title":"Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver","volume":"91","author":"Nakai","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.regpep.2007.09.012_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.regpep.2007.09.012_bib65","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.70.7.4646-4654.1996","article-title":"A \u201chumanized\u201d green fluorescent protein cDNA adapted for high-level expression in mammalian cells","volume":"70","author":"Zolotukhin","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.regpep.2007.09.012_bib66","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","article-title":"Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein","volume":"93","author":"Kessler","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.09.012_bib67","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.regpep.2007.09.012_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JVI.70.1.520-532.1996","article-title":"Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis","volume":"70","author":"Fisher","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.regpep.2007.09.012_bib69","first-page":"455","article-title":"Methods for adeno-associated virus-mediated gene transfer into muscle","volume":"175","author":"Amiss","year":"2001","journal-title":"Method Mol Biol"},{"key":"10.1016\/j.regpep.2007.09.012_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/en.2003-0366","article-title":"Gene therapy for central diabetes insipidus: effective antidiuresis by muscle-targeted gene transfer","volume":"145","author":"Yoshida","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2007.09.012_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02982689","article-title":"Adeno-associated virus-mediated gene transfer for hemophilia B","volume":"76","author":"High","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.regpep.2007.09.012_bib72","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.94.25.13921","article-title":"Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin","volume":"94","author":"Murphy","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.09.012_bib73","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood.V95.9.2793.009k07_2793_2798","article-title":"Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle","volume":"95","author":"Bohl","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.regpep.2007.09.012_bib74","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.regpep.2007.09.012_bib75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2000.tb06954.x","article-title":"Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP","volume":"921","author":"Leceta","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2007.09.012_bib76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0165-5728(99)00244-1","article-title":"The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells","volume":"104","author":"Wang","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2007.09.012_bib77","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.167.2.966","article-title":"Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo","volume":"167","author":"Delgado","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2007.09.012_bib78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1073\/pnas.012367999","article-title":"Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor","volume":"99","author":"Martinez","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.09.012_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/cyto.2002.1024","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1a production and mRNA expression","volume":"18","author":"Pozo","year":"2002","journal-title":"Cytokine"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:13:28Z","timestamp":1737429208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011507001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":79,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0167011507001899"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2007.09.012","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}